Skip to main content
Caplight Logo









Genome Wisdom

Genome Wisdom

Private
BeijingHealthcare & Life Scienceshttps://genowis.com

Last Round

Corporate Funding

Jun 1, 2022

Total Funding Raised

$14.46M

Company Overview

Genome Wisdom is a precision medical big data company that provides integrated solutions for tumor diagnosis using multi-modal artificial intelligence, genomics, and bioinformatics.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical AI, Healthcare Analytics, Biotechnology

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

precision medicinenext-generation sequencingNGSoncology diagnosticspathology imagingbioinformaticsclinical decision supportbiomarker discoverydigital pathologyAI diagnosticscomputational pathologygenomic data analysismedical AIhealth techSaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genome Wisdom Comparables

Compare Genome Wisdom with similar companies based on industry and business-model similarity.

Genome Wisdom comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
求臻医学
85%
Genecast
80%
Geneseeq
78%

Genome Wisdom Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingJun 1, 2022
Series BNov 22, 2019
Series AApr 1, 2018
AngelJul 1, 2016

Genome Wisdom Investors

Notable investors and investment history

Genome Wisdom investors
InvestorRounds
Phoenix Tree CapitalSeries B
ZhenFundAngel
Legend CapitalSeries B, Series A
Leading The Trend InvestmentAngel
Huagai CapitalSeries B
Legend HoldingsSeries A
Zhencheng CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2022

    Raised $6M from Shanghai Labway Clinical Laboratory Co., Ltd.

  • Nov 22, 2019

    Raised $9M led by Huagai Capital

Genome Wisdom Filings

Explore SEC and related filing metadata, where available.

Genome Wisdom filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Genome Wisdom's valuation, stock price, and market status.

Is Genome Wisdom a public or private company?

Genome Wisdom is a private company.

What is the current stock price of Genome Wisdom?

Genome Wisdom is a private company, so its shares have no public market price. Caplight tracks Genome Wisdom's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Genome Wisdom worth (valuation)?

Valuation information for Genome Wisdom is not publicly available.

Can I buy Genome Wisdom stock?

Genome Wisdom shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Genome Wisdom's last funding round?

Genome Wisdom's most recent funding round was Corporate Funding on June 1, 2022.

Who are the main investors in Genome Wisdom?

Key investors in Genome Wisdom include ZhenFund, Legend Capital, Huagai Capital.

Will Genome Wisdom IPO soon?

No public IPO plans have been announced for Genome Wisdom.

How can I track Genome Wisdom secondary market activity?

Caplight tracks bids, offers, and trades in Genome Wisdom's shares on secondary markets.

Firmographic Details

HeadquartersBeijing
Employee Range3
Year Founded2015
Last FundingJun 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?